XML 42 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Segment information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Significant Segment Expenses

 

   2024   2023 
   Year ended
December 31,
 
   2024   2023 
Revenue  $-   $- 
           
Less:          
Research and development   (772,702)   (279,489)
Payroll and related   (1,093,327)   (1,174,239)
Insurance   (209,922)   (674,976)
Professional fees primarily related to intellectual property   (895,682)   (963,926)
Operating expenses   (651,509)   (730,996)
Sale of royalty and milestone rights, net of transaction costs   2,000,000    4,167,219 
Other income   33,456    56,850 
Net income (loss)  $(1,589,686)  $400,443